Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome
Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of levetiracetam for
treating alcohol withdrawal syndrome (AWS) in inpatients (vs. placebo). The primary come-out
parameter is the reduction of the total needed amount of diazepam for add-on treatment of
acute alcohol withdrawal symptoms. The secondary come-out parameter are - safety criteria
(AE) - reduction of alcohol withdrawal score over the days.